Antibody-drug conjugates (ADC) companies

As of Oct 2026, Radar classifies 74 companies as Antibody-drug conjugates (ADC); 8 of them have job postings observed in our sources.

Draft page: not yet published to search engines (owner review pending).

Dots are city centers, sized by number of companies. Largest: South San Francisco, CA 4; San Diego, CA 3; Cambridge, MA 2; San Carlos, CA 2; Cleveland, OH 1. Map: US Census.

Companies

Merck & Co., Inc. FDA-approved therapeutic company FDA-cleared device company Clinical Phase 3
Rahway, NJ · Antibody-drug conjugates (ADC), Biosimilars, Bispecific antibodies · 939 jobs observed · 1369 trials (lead sponsor)
Gilead FDA-approved therapeutic company Clinical Phase 3
Antibody-drug conjugates (ADC), Biosimilars, Monoclonal antibodies · 519 jobs observed · 694 trials (lead sponsor)
Ipsen FDA-approved therapeutic company Clinical Phase 3
Antibody-drug conjugates (ADC), Peptide, Radiopharma · 269 jobs observed · 288 trials (lead sponsor)
IDEAYA Biosciences Clinical Phase 3
South San Francisco, CA · Antibody-drug conjugates (ADC), Small molecule · 40 jobs observed · 11 trials (lead sponsor)
Iambic Therapeutics Clinical Phase 1
Antibody-drug conjugates (ADC) · 32 jobs observed · 1 trial (lead sponsor)
Immunome Clinical Phase 3
Bothell, WA · Antibody-drug conjugates (ADC), Radiopharma, Small molecule · 28 jobs observed · 10 trials (lead sponsor)
Sutro Biopharma Clinical Phase 3
South San Francisco, CA · Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · 5 jobs observed · 8 trials (lead sponsor)
TwoStep Therapeutics Clinical Phase 1
San Carlos, CA · Antibody-drug conjugates (ADC), Bispecific antibodies, Radiopharma · 1 job observed · 1 trial (lead sponsor)
AbBC Therapies
Antibody-drug conjugates (ADC) · No hiring observed in our sources
Abcon Therapeutics
Cleveland, OH · Antibody-drug conjugates (ADC), Monoclonal antibodies · No hiring observed in our sources
Accent Therapeutics Clinical Phase 2
Antibody-drug conjugates (ADC), Small molecule · No hiring observed in our sources · 2 trials (lead sponsor)
Adcentrx Therapeutics Clinical Phase 1
Antibody-drug conjugates (ADC) · No hiring observed in our sources · 2 trials (lead sponsor)
Aera Therapeutics
Antibody-drug conjugates (ADC), Delivery: lipid nanoparticles (LNP), Gene therapy · No hiring observed in our sources
Akari Therapeutics
Tampa, FL · Antibody-drug conjugates (ADC), Monoclonal antibodies · No hiring observed in our sources
Alphina Therapeutics
Antibody-drug conjugates (ADC), Monoclonal antibodies · No hiring observed in our sources
Angiex, Inc. Clinical Phase 1
Cambridge, MA · Antibody-drug conjugates (ADC), Monoclonal antibodies · No hiring observed in our sources · 1 trial (lead sponsor)
Antharis Therapeutics
San Diego, CA · Antibody-drug conjugates (ADC), Monoclonal antibodies · No hiring observed in our sources
Antigenix Therapeutics
Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources
Anwita Biosciences Clinical Phase 1
Antibody-drug conjugates (ADC), Proteins / enzymes · No hiring observed in our sources · 3 trials (lead sponsor)
Avenzo Therapeutics Clinical Phase 2
Antibody-drug conjugates (ADC) · No hiring observed in our sources · 4 trials (lead sponsor)
BioAtla, Inc. Clinical Phase 2
San Diego, CA · Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 6 trials (lead sponsor)
Biohaven Clinical Phase 3
New Haven, CT · Antibody-drug conjugates (ADC), Bispecific antibodies, Small molecule · No hiring observed in our sources · 34 trials (lead sponsor)
BiOneCure Therapeutics Inc.
Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources
Callio Therapeutics Clinical Phase 2
Antibody-drug conjugates (ADC), Monoclonal antibodies · No hiring observed in our sources · 1 trial (lead sponsor)
Canwell Pharma Clinical Phase 1
Antibody-drug conjugates (ADC), Monoclonal antibodies, Small molecule · No hiring observed in our sources · 1 trial (lead sponsor)
Catena Biosciences
Antibody-drug conjugates (ADC) · No hiring observed in our sources
Corbus Pharmaceuticals Clinical Phase 3
Norwood, MA · Antibody-drug conjugates (ADC) · No hiring observed in our sources · 10 trials (lead sponsor)
Cypre
San Francisco, CA · Antibody-drug conjugates (ADC), Bispecific antibodies · No hiring observed in our sources
Daiichi Sankyo FDA-approved therapeutic company Clinical Phase 3
Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 393 trials (lead sponsor)
DEM BioPharma Clinical Phase 1
Cambridge, MA · Antibody-drug conjugates (ADC), Monoclonal antibodies · No hiring observed in our sources · 1 trial (lead sponsor)
Differentia Biotech
Antibody-drug conjugates (ADC), AI drug discovery, Monoclonal antibodies · No hiring observed in our sources
Dren Bio Clinical Phase 2
San Carlos, CA · Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 7 trials (lead sponsor)
Eli Lilly FDA-approved therapeutic company FDA-cleared device company Clinical Phase 3
Antibody-drug conjugates (ADC), Bispecific antibodies, Digital health · No hiring observed in our sources · 2090 trials (lead sponsor)
Empiriko
Antibody-drug conjugates (ADC), Diagnostics, Diagnostics: in vitro (IVD) · No hiring observed in our sources
Firefly Bio
Antibody-drug conjugates (ADC) · No hiring observed in our sources
Fortitude Biomedicines
Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources
Genmab FDA-approved therapeutic company Clinical Phase 3
Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 68 trials (lead sponsor)
Karyopharm Therapeutics Inc. FDA-approved therapeutic company Clinical Phase 3
Newton, MA · Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 37 trials (lead sponsor)
Klus Pharma Clinical Phase 2
Princeton, NJ · Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 4 trials (lead sponsor)
Kyowa Hakko Kirin FDA-approved therapeutic company
Antibody-drug conjugates (ADC), Gene therapy, Monoclonal antibodies · No hiring observed in our sources
Lantern Pharma Clinical Phase 2
Dallas, TX · Antibody-drug conjugates (ADC), AI drug discovery, Small molecule · No hiring observed in our sources · 3 trials (lead sponsor)
Lytica Therapeutics
Antibody-drug conjugates (ADC) · No hiring observed in our sources
MacroGenics Clinical Phase 3
Rockville, MD · Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 42 trials (lead sponsor)
Manhattan Biosolutions
Antibody-drug conjugates (ADC), Monoclonal antibodies · No hiring observed in our sources
MarWell Bio
South San Francisco, CA · Antibody-drug conjugates (ADC), AI drug discovery, Monoclonal antibodies · No hiring observed in our sources
MBrace Therapeutics Clinical Phase 2
San Diego, CA · Antibody-drug conjugates (ADC), Monoclonal antibodies · No hiring observed in our sources · 2 trials (lead sponsor)
Medicovestor
Antibody-drug conjugates (ADC) · No hiring observed in our sources
Multitude Therapeutics
Antibody-drug conjugates (ADC), Monoclonal antibodies · No hiring observed in our sources
Nanovalent Pharmaceuticals
Antibody-drug conjugates (ADC), Monoclonal antibodies · No hiring observed in our sources
NEOK Bio Clinical Phase 1
Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 2 trials (lead sponsor)
Oncotherapy Solutions
Seattle, WA · Antibody-drug conjugates (ADC), Bispecific antibodies, Peptide · No hiring observed in our sources
Oqory
Antibody-drug conjugates (ADC), Monoclonal antibodies · No hiring observed in our sources
Oxford BioTherapeutics Clinical Phase 1
Antibody-drug conjugates (ADC), AI drug discovery, Tools, reagents and instruments · No hiring observed in our sources · 1 trial (lead sponsor)
Pyxis Oncology, Inc Clinical Phase 2
Boston, MA · Antibody-drug conjugates (ADC), Monoclonal antibodies · No hiring observed in our sources · 3 trials (lead sponsor)
Rondo Therapeutics Clinical Phase 1
Hayward, CA · Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 1 trial (lead sponsor)
Saccharo
Antibody-drug conjugates (ADC) · No hiring observed in our sources

Showing 60 of 74. Filter in Discover